Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | Biondi Paul | Director | Jul 05, 2022 | Option Exercise | $3.15 | 47,619 | 150,000 | 47,619 | Jul 06, 2022, 07:19 PM | |
BMY | BRISTOL MYERS SQUIBB CO | Biondi Paul | SVP, Head of Strategy & BD | Oct 02, 2019 | Option Exercise | $49.21 | 203 | 9,990 | 6,214 | Oct 03, 2019, 04:46 PM | |
BMY | BRISTOL MYERS SQUIBB CO | Biondi Paul | SVP, Head of Strategy & BD | Oct 02, 2018 | Option Exercise | $62.80 | 292 | 18,338 | 1,041 | May 06, 2019, 04:39 PM | |
BMY | BRISTOL MYERS SQUIBB CO | Biondi Paul | SVP, Head of Strategy & BD | Mar 10, 2019 | Option Exercise | $51.39 | 3,188 | 163,831 | 5,825 | Mar 13, 2019, 07:39 AM | |
BMY | BRISTOL MYERS SQUIBB CO | Biondi Paul | SVP, Head of Strategy & BD | Oct 02, 2018 | Option Exercise | $62.80 | 292 | 18,338 | 300 | Oct 04, 2018, 04:56 PM | |
BMY | BRISTOL MYERS SQUIBB CO | Biondi Paul | SVP, Head of Strategy & BD | Jul 01, 2018 | Option Exercise | $55.34 | 720 | 39,845 | 741 | Jul 03, 2018, 09:24 PM |